Mohit Rawat - 27 Sep 2021 Form 4 Insider Report for Fusion Pharmaceuticals Inc.

Role
President and CBO
Signature
/s/Maria Stahl as Attorney-in-Fact for Mohit Rawat
Issuer symbol
N/A
Transactions as of
27 Sep 2021
Net transactions value
$0
Form type
4
Filing time
30 Sep 2021, 16:06:26 UTC
Next filing
03 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Option (Right to Buy) Award $0 +257,000 $0.000000 257,000 27 Sep 2021 Common Stock 257,000 $8.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the shares subject to this option shall vest and become exercisable on the first anniversary of the grant date and the remainder shall vest and become exercisable in 36 substantially equal monthly installments thereafter.